SCHEMBL26699658

SCHEMBL26699658

CP(C)(=O)c1ccc(CN)c(C(F)(F)F)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
NR1H2 P55055 1/20 0.36
SLC6A2 P23975 6/20 0.33
SLC6A4 P31645 6/20 0.33
EPHX2 P34913 3/20 0.33
GLA P06280 1/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
SLC6A3 Q01959 1/20 0.31
POLQ O75417 3/20 0.31
PDE3B Q13370 1/20 0.30
PDE3A Q14432 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26699671 0.77 LOXL2 (0.36) IDO1
SCHEMBL30184485 0.77 FFAR4 (0.40) GLAPOLBGAATSHR
SCHEMBL25033109 0.77 FFAR4 (0.40) GLAPOLBGAATSHR
SCHEMBL545969 0.74 GAA (0.57) IDO1NR1H2GLAPOLBGAA
SCHEMBL109671 0.74 IDO1 (0.65) IDO1SLC6A2SLC6A4HDAC3HDAC1
SCHEMBL25327887 0.74 MAPT (0.43) PDE3BPDE3A
SCHEMBL25935807 0.73 DDR1 (0.46) SLC6A2SLC6A4EPHX2SLC6A3
SCHEMBL14224743 0.73 SMN1; SMN2 (0.42) IDO1NR1H2SLC6A2SLC6A4HTR2A
SCHEMBL964552 0.71 DAO (0.46) IDO1TSHRPOLQ
SCHEMBL31532451 0.70 SLC6A4 (0.34) SLC6A2SLC6A4HDAC6SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023226950-A1 PEPTIDOMIMETIC STAT PROTEIN DEGRADER, COMPOSITION AND USE THEREOF 杭州和正医药有限公司 2023-11-30 WO disclosed
CN-117126231-A Peptoid STAT protein degradation agent, composition and application thereof 杭州和正医药有限公司 2023-11-28 CN disclosed